Researchers at MIT have harnessed artificial intelligence to design novel antibiotics targeting drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). By computationally screening millions of AI-generated molecules, the team identified candidates structurally distinct from existing drugs that disrupt bacterial membranes through new mechanisms. This development exemplifies AI-driven innovation in antibiotic discovery, aiming to overcome resistance challenges threatening global health.